Annual Congress Barcelona 2010

Saturday, 18.09.2010
Sunday, 19.09.2010
Monday, 20.09.2010
Tuesday, 21.09.2010
Wednesday, 22.09.2010

Citations should be made in the following way: Authors. Title. Eur Respir J 2010; 36: Suppl. 54, abstract number.

Material from 2010:

4910 Abstracts
646 Slide presentations
250 Webcasts
97 Handouts
2124 e-posters
250 Multimedia files

Material from 2010: Show

Pulmonary hypertension updates

Oral Presentation
Chairs: A. Peacock (Clydebank, United Kingdom), R. Naeije (Brussels, Belgium)

Download all media

Current management of patients with chronic thromboembolic pulmonary hypertension J. Pepke-Zaba, E. Mayer, M. Delcroix, G. Simonneau, I. Lang (Cambridge, United Kingdom; Bad Nauheim, Germany; Leuven, Belgium; Paris, France; , Austria)
Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study O. Sanchez, L. Guérin, F. Couturaud, F. Parent, D. Pontal, G. Simonneau, G. Meyer (Brest, Clamart, France)
Poor subpleural perfusion as a predictor for a poor outcome in chronic thromboembolic pulmonary hypertension N. Tanabe, T. Sugiura, S. Sakao, Y. Kasahara, M. Saito, S. Kitazono, T. Jujyo, H. Amano, Y. Takiguchi, M. Masuda, K. Tatsumi (Chiba, Japan)
Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study H. A. Ghofrani, M. M. Hoeper, M. Halank, F. J. Meyer, G. Staehler, J. Behr, R. Ewert, T. Binnen, G. Weimann, F. Grimminger, on Behalf of the Study Investigators (Hannover, Dresden, Heidelberg, Greifswald, Leverkusen, Wuppertal, Germany)
Efficacy and safety of bosentan in portopulmonary hypertension according to the severity of liver disease L. Savale, R. Magnier, J. Le Pavec, X. Jaïs, D. O‘Callaghan, D. Montani, D. Natali, M. Humbert, G. Simonneau, O. Sitbon (Clamart, Caen, France)
Non-invasive parameters can predict out of proportion pulmonary hypertension (PH) in conjunction with heart failure and preserved systolic function (HFPSF) in patients with moderate to severe PH R. Wolff, O. Amir, T. Pesachovitz, I. Lavi, B. Lewis, N. Peled, Y. Adir (Haifa, Israel)
Absence of influence of gender on clinical phenotypes in BMPR2 mutation carriers with pulmonary arterial hypertension from the French registry B. Girerd, D. Montani, G. Simonnneau, F. Soubrier, M. Humbert (Clamart, Paris, France)
2-year outcomes in newly and previously diagnosed patients with pulmonary arterial hypertension enrolled in REVEAL A. Frost, D. Badesch, D. Miller, R. Benza, M. McGoon (Houston, Denver, San Francisco, Pittsburgh, Rochester, United States Of America)